Nitrogen → N-{[2-(cyclopropylethynyl)-1,3-thiazol-4-yl]methoxy}-1-(1-methyl-1H-tetrazol-5-yl)-1-phenylmethanimine
反応式
Br[C:2]1[S:3][CH:4]=[C:5]([CH2:7][O:8][N:9]=[C:10]([C:17]2[N:21]([CH3:22])[N:20]=[N:19][N:18]=2)[C:11]2[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=2)[N:6]=1.N#N.[CH:25]1([C:28]#[CH:29])[CH2:27][CH2:26]1.C(N(C(C)C)C(C)C)C>C1COCC1.CCOC(C)=O.[Cu]I.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH:25]1([C:28]#[C:29][C:2]2[S:3][CH:4]=[C:5]([CH2:7][O:8][N:9]=[C:10]([C:17]3[N:21]([CH3:22])[N:20]=[N:19][N:18]=3)[C:11]3[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=3)[N:6]=2)[CH2:27][CH2:26]1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 4
実験手順
To a stirred solution of N-[(2-bromo-1,3-thiazol-4-yl)methoxy]-1-(1-methyl-1H-tetrazol-5-yl)-1-phenylmethanimine (1 g, 2.63 mmol, 1 eq.) in 20 ml dry THF “degassed” with N2, was added cyclopropylacetylene (70%, 0.996 g, 10.54 mmol, 4 eq.) followed by N-ethyldiisopropylamine (1.36 g, 10.54 mmol, 4 eq.), Copper(I) Iodide (0.025 g, 0.132 mmol, 0.05 eq.) and Tetrakis(triphenylphosphine)palladium (0.152 g, 0.132 mmol, 0.05 eq.). The reaction was stirred for 20 hrs at room temperature for complete conversion. The reaction mixture was diluted with EtOAc (50 ml), filtered through “Chem Elut” cartridge, washed with fresh EtOAc (2×20 ml) and the filtrate was evaporated. The residue was purified by chromatography on silica gel to give N-{[2-(cyclopropylethynyl)-1,3-thiazol-4-yl]methoxy}-1-(1-methyl-1H-tetrazol-5-yl)-1-phenylmethanimine (0.57 g, 60% yield, single stereoisomer) as a brown gum.
後処理
- filtrationfiltered through “Chem Elut” cartridge
- washwashed with fresh EtOAc (2×20 ml)
- customthe filtrate was evaporated
- customThe residue was purified by chromatography on silica gel
出典と根拠
- ORDレコード
- ord-81021db69605417684d16fe436fa6423
- 出典データセット
- uspto-grants-2013_06
- 特許番号
- US08466176B2
反応ノート
読み込み中…